Medications

US approves highly anticipated Eli Lilly weight loss drug

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.

Parkinson's & Movement disorders

Parkinson's research: New hope when treatment options seem exhausted

As Parkinson's progresses, more invasive therapies are used, for example, those that require brain surgery. When these therapies no longer deliver the desired results, physicians often conclude that treatment options are ...

page 8 from 40